Ono Pharmaceutical Co., Ltd. (4528) Press Release
Consolidated Financial Results for the First Quarter of Fiscal Year Ending March 31, 2027 (IFRS)
Earlier from Ono Pharmaceutical
- Ono Pharmaceutical: Notice concerning Completion of Disposal of Treasury Shares as Tenure-based Restricted Stock Compensation and Performance-linked Restricted Stock Compensation
- Ono Pharmaceutical: Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement of Malignant Lymphoma in Patients with Inadequate Response to Existing Therapies or in Whom Such Therapies Are Not Appropriate
- Oncolys BioPharma: Announces Full Marketing Approval in Japan for Telomelysin for the Treatment of Esophageal Cancer